We are an award-winning pediatric biotechnology startup working with clinicians to help improve the treatment of newborns with specific medical conditions - especially those where breathing and heart rate are a concern. Over a decade ago, clinicians and scientists developed a unique vibrating pad to help newborns breathe, relax and sleep. At Prapela, we're working to make this breakthrough available to help infants and their caregivers everywhere. Our extremely gentle vibration moves randomly within a very narrow range of up & down movement and speed. It's based on a field of science called Stochastic Resonance which explains that biological processes (like breathing and heart rate) can be improved with random stimulation. For more information, visit prapela.com
Location: United States, Maine, Biddeford
Employees: 1-10
Phone: +1 833-772-7352
Founded date: 2017
Investors 2
| Date | Name | Website |
| - | SWPDC | swpdc.org/ |
| - | MassChalle... | masschalle... |
Mentions in press and media 4
| Date | Title | Description |
| 17.04.2025 | Prapela, Inc. Granted FDA De Novo for Breakthrough Therapy Helping the Most Vulnerable Victims of our Opioid Epidemic | Prapela SVS hospital bassinet basked inside a standard-size bassinet basket Prapela’s SVS hospital bassinet pad is the first and only therapeutic medical device to treat opioid exposed newborns with neonatal opioid withdrawal syndrome. PORT... |
| 23.05.2018 | Announcing the 2018 MassChallenge Boston Cohort | We’re thrilled to introduce this year’s MassChallenge Boston cohort, which was selected from more than 1,600 applications from around the world, including 11 countries and 16 U.S. states. Representing the top 8% of all applicants, these 128... |
| 11.12.2012 | Biotechnology startup raises $11M for small molecule therapeutic to treat cancer, fibrosis | Galera Therapeutics‘ superoxide dismutase mimetics are small molecules that mimic the effect of the superoxide dismutase enzyme’s properties. Newly appointed CEO Dr. Mel Sorensen told MedCity News in a phone interview that the technology wa... |
| - | Biotechnology startup raises $11M for small molecule therapeutic to treat cancer, fibrosis | A biotechnology startup has figured out a way to harness a natural antioxidant defense for cells and apply it to treating conditions ranging from mucositis — a common side effect of chemotherapy and radiation therapy for head and neck cance... |